SMARCD3 and neoplasm: ATF5 was significantly expressed on Mono/Macro and pDC subgroups in tumor cells, whereas C1orf53 was predominantly expressed on Mono/Macro subgroup and SMARCD3 was predominantly expressed on Mast subgroup (Figure S10f).